BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17241110)

  • 21. Receptor for advanced glycation end products (RAGE) on iNKT cells mediates lung ischemia-reperfusion injury.
    Sharma AK; LaPar DJ; Stone ML; Zhao Y; Kron IL; Laubach VE
    Am J Transplant; 2013 Sep; 13(9):2255-67. PubMed ID: 23865790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.
    Lue LF; Yan SD; Stern DM; Walker DG
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):249-66. PubMed ID: 15975028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of RAGE suppresses peripheral nerve regeneration.
    Rong LL; Trojaborg W; Qu W; Kostov K; Yan SD; Gooch C; Szabolcs M; Hays AP; Schmidt AM
    FASEB J; 2004 Dec; 18(15):1812-7. PubMed ID: 15576484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
    Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor for advanced glycation end products: fundamental roles in the inflammatory response: winding the way to the pathogenesis of endothelial dysfunction and atherosclerosis.
    Ramasamy R; Yan SF; Herold K; Clynes R; Schmidt AM
    Ann N Y Acad Sci; 2008 Apr; 1126():7-13. PubMed ID: 18448789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo.
    Moser B; Desai DD; Downie MP; Chen Y; Yan SF; Herold K; Schmidt AM; Clynes R
    J Immunol; 2007 Dec; 179(12):8051-8. PubMed ID: 18056345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.
    Bucciarelli LG; Wendt T; Rong L; Lalla E; Hofmann MA; Goova MT; Taguchi A; Yan SF; Yan SD; Stern DM; Schmidt AM
    Cell Mol Life Sci; 2002 Jul; 59(7):1117-28. PubMed ID: 12222959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Aminolevulinic acid with ferrous iron induces permanent cardiac allograft acceptance in mice via induction of regulatory cells.
    Hou J; Zhang Q; Fujino M; Cai S; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Xu J; Zou H; Ding Q; Li XK
    J Heart Lung Transplant; 2015 Feb; 34(2):254-63. PubMed ID: 25455753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding RAGE, the receptor for advanced glycation end products.
    Bierhaus A; Humpert PM; Morcos M; Wendt T; Chavakis T; Arnold B; Stern DM; Nawroth PP
    J Mol Med (Berl); 2005 Nov; 83(11):876-86. PubMed ID: 16133426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
    Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
    J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposing roles of RAGE and Myd88 signaling in extensive liver resection.
    Zeng S; Zhang QY; Huang J; Vedantham S; Rosario R; Ananthakrishnan R; Yan SF; Ramasamy R; DeMatteo RP; Emond JC; Friedman RA; Schmidt AM
    FASEB J; 2012 Feb; 26(2):882-93. PubMed ID: 22075646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
    Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
    Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
    Nathan MJ; Yin D; Eichwald EJ; Bishop DK
    Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE)--an introduction.
    Thornalley PJ
    Mol Nutr Food Res; 2007 Sep; 51(9):1107-10. PubMed ID: 17854008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
    Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
    Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.
    Teismann P; Sathe K; Bierhaus A; Leng L; Martin HL; Bucala R; Weigle B; Nawroth PP; Schulz JB
    Neurobiol Aging; 2012 Oct; 33(10):2478-90. PubMed ID: 22227007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent role of donor dendritic cells in rejection versus tolerance of allografts.
    Ueno T; Tanaka K; Jurewicz M; Murayama T; Guleria I; Fiorina P; Paez JC; Augello A; Vergani A; Wong M; Smith RN; Abdi R
    J Am Soc Nephrol; 2009 Mar; 20(3):535-44. PubMed ID: 19129312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.